Market revenue in 2022 | USD 15.1 million |
Market revenue in 2030 | USD 34.2 million |
Growth rate | 10.8% (CAGR from 2022 to 2030) |
Largest segment | 13-24 weeks |
Fastest growing segment | 0-12 weeks |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 52.32% in 2022. Horizon Databook has segmented the Thailand non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
The demand for NIPT is increasing in Thailand due to a variety of factors such as a rising number of doctors opting for advanced genetic analysis for high-risk pregnancies, a wish to postpone pregnancy, and an increase in pregnancy-related problems in the third or second trimester.
Invasive prenatal testing methods, such as chorionic villus sampling & amniocentesis, can result in complications such as miscarriage. As a result, the use of these procedures has decreased, and there is a high demand for tests that are more effective, noninvasive, and secure.
NIPT, through the use of cell-free fetal DNA that circulates in the mother’s blood, is suitable for the identification of commonly occurring trisomy in the fetus, such as turner syndrome, down syndrome, fetal rhesus D status, and sex chromosome disorders and determination of fetal sex.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into Thailand non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account